Fresenius Medical Care AG & Co. KGaA / Fundamentals
Income statement
- Net revenue
€19.52B - Cost of goods sold
€14.70B - Gross profit
€4.81B - SG&A expenses
€3.14B - R&D expenses
€172.09M - EBITDA
€3.09B - D&A
€1.61B - EBIT
€1.48B - Interest expenses
€392.34M - EBT
€1.12B - Tax expenses
€316.36M - Net income
€656.43M
Cash flow statement
- Net deferred tax
-€81.75M - Non-cash items
-€219.59M - Changes in working capital
€648.39M - Operating cash flow
€2.75B - Capex
€700.41M - Other investing cash flow
€1.02B - Net investing cash flow
-€578.46M - Total cash dividends paid
-€422.52M - Issuance of common stock
€0.00 - Debt repayment
€468.16M - Other financing cash flow
-€105.21M - Net financing cash flow
-€59.57M - Foreign exchange effects
-€93.09M - Net change in cash
€534.81M - Cash at end of period
€1.72B - Free cash flow
€3.45B
Balance sheet
- Cash and cash equivalents
€1.72B - Cash and short-term investments
€2.19B - Total receivables
€3.23B - Inventory
€2.00B - Other current assets
€718.27M - Total current assets
€8.14B - Property, plant & equipment
€6.50B - Goodwill
€13.62B - Intangible assets
€1.25B - Long-term investments
€1.34B - Other non-current assets
€213.01M - Total non-current assets
€23.16B - Total assets
€31.29B - Accounts payable
€751.75M - Short-term debt
€1.60B - Other current liabilities
€3.14B - Total current liabilities
€5.66B - Long-term debt
€9.42B - Deferred tax liabilities
€612.95M - Other non-current liabilities
€1.27B - Total non-current liabilities
€11.30B - Total liabilities
€16.96B - Common stock
€293.41M - Retained earnings
€11.29B - Other equity
-€1.66B - Total equity
€14.33B - Total liabilities and shareholders' equity
€31.29B
Company information
- Market capitalization
€14.12B - Employees
112K - Enterprise Value
€24.35B
Company ratios
- Gross margin
-
24.7% Much worse than peer group: 48.4% - EBITDA margin
-
15.8% Even with peer group: 14.5% - EBIT margin
-
7.6% Even with peer group: 10.6% - EBT margin
-
5.7% Even with peer group: 5.9% - Net margin
-
3.4% Even with peer group: 3.3% - ROE
-
4.6% Much better than peer group: -42.7% - ROA
-
2.1% Even with peer group: 3.5% - Asset turnover
-
62.4% Much worse than peer group: 98.2% - FCF margin
-
10.5% Better than peer group: 2.8% - FCF yield
14.5% - Efficiency ratio
84.2% - Net sales per employee
-
€174.21K - Net income per employee
-
€5.86K